Advances in Muscle Stem Cells and Development

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell and Gene Therapy".

Deadline for manuscript submissions: 20 July 2024 | Viewed by 186

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD 20892, USA
Interests: muscle stem cells; epigenetics; development; multi-omics

Special Issue Information

Dear Colleagues,

Muscle stem cells (MuSCs) are the resident stem cells in skeletal muscle tissues. They derive from myogenic precursors during development and gradually settle in the adult muscle niche along the course of muscle growth and homeostasis. MuSCs stay quiescent under normal conditions, while they could be activated upon injury and stress to regenerate and repair the tissue. During regeneration, a subset of them also returns to quiescence to sustain the stem cell pool, a quintessential character of adult stem cells. MuSCs’ function relates to homeostasis and a lot of myopathies, including atrophy, muscular dystrophy, and aging. Not surprisingly, they hold great therapeutic value and potential. Although signaling pathways, metabolism, and epigenetic remodeling intrinsic to MuSCs were proved to be essential to the fate and functions of them, more recent studies suggested that other cell types in the muscle tissue, such as fibro/adipogenic progenitors (FAPs), endothelial cells, and macrophages, also send critical signals to regulate their function during regeneration. With advances in deep sequencing, more and more transcriptomics, epigenomics, and multi-omics data with single-cell resolution or with spatial context on MuSCs have come out in the last five years. This provides a larger blueprint to study and test MuSCs under different physiological conditions and aging. It has never been this exciting to gain knowledge on the field of muscle biology and to test new ways to treat muscle diseases. Therefore, in this Special Issue, we invite labs to submit their new discoveries and review recent advances and perspectives in the field of muscle stem cells to extend our knowledge on this subject.

Dr. Xuesong Feng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • muscle stem cells
  • development
  • myogenesis
  • regeneration
  • myopathies

Published Papers

This special issue is now open for submission.
Back to TopTop